VirTra (VTSI) Q2 2024 earnings summary

Executive summary

• Q2 2024 revenue was $6.1 million, down 41% year-over-year due to delayed federal and government contracts and budget decisions.

• Gross margin reached a record 91%, up from 57% last year, driven by operational efficiencies, favorable sales mix, and a higher proportion of STEP and service contracts.

• Net income rose 17% to $1.2 million ($0.11 per diluted share), despite lower revenue, reflecting strong cost control and margin management.

• Bookings doubled quarter-over-quarter to $5.9 million, and backlog was $313.8 million as of June 30, 2024.

• Strategic initiatives included the launch of the V-XR platform, expansion into healthcare training, and appointment of Brandon Cox as CTO.

Financial highlights

• Q2 2024 revenue: $6.1 million, down from $10.3 million in Q2 2023 (–41% year-over-year).

• Gross profit: $5.5 million (91% margin), up from 57% margin last year.

• Net income: $1.2 million, up from $1 million in Q2 2023; diluted EPS $0.11.

• Adjusted EBITDA: $1.6 million, down from $2.6 million year-over-year.

• Cash and equivalents at June 30, 2024: $18.4 million; working capital: $34.8 million.

Outlook and guidance

• Management expects most new capital bookings from H1 2024 to convert to revenue in 2024, with a strong sales pipeline and backlog.

• Gross margin is expected to normalize to the low 60% range, with potential temporary dips to the high 50s as new products launch.

• V-XR extended reality solution to begin shipping by end of Q3 2024, targeting law enforcement, military, healthcare, and education.

• Management is optimistic for the second half of 2024 as grant funding and military contracts are expected to improve.

• Current capital resources are expected to support operations for more than 12 months; open to raising additional funds for expansion.